Entrepreneurship studio logo

Entrepreneurship Studio

AI•

Funding

BrainSightAI Secures $5 Million in Pre-Series A Funding Led by IAN Alpha Fund

A woman seated, dressed in a blazer and black pants, holding a phone. The background is dark with flowing green lines, and the "BrainSightAI" logo features a brain illustration integrated with connected nodes.
By
E-Studio
2 min read

Bengaluru-based deep-tech neuroscience startup BrainSightAI has raised $5 million in a pre-Series A funding round led by IAN Alpha Fund. The funding round also saw participation from IvyCap Ventures, Silver Needle, and other existing investors.

Expansion and Certification Plans

The capital raised will be allocated toward several key initiatives:

  • Domestic Expansion: Extending BrainSightAI's services across India, focusing on Tier II cities to reach a broader audience.
  • Global Certifications: Pursuing FDA certification to facilitate entry into international markets, including the United States.
  • International Outreach: Exploring opportunities in regions such as Africa and Southeast Asia to establish a global presence.
  • Innovation in Patient Care: Developing a caregiver-centric application aimed at assisting families dealing with neurological disorders.

About BrainSightAI

Founded in 2019 by CEO Laina Emmanuel and CTO Dr. Rimjhim Agrawal, BrainSightAI leverages artificial intelligence to advance the diagnosis and treatment of neuro-oncological and neuropsychiatric conditions. The company’s core products include:

  • VoxelBox: A functional MRI (fMRI) processing engine that uses machine learning to assist clinicians in pre-surgical planning.
  • Snowdrop: A patient care application designed to enhance treatment compliance and offer detailed patient profiling.

BrainSightAI collaborates with over 40 hospitals across India, primarily focusing on neurosurgery and radiology departments treating brain tumor cases.

Investor Insights

Priyank Garg, Managing Partner at IAN Alpha Fund, emphasized the transformative potential of BrainSightAI's technology. He highlighted how the company's innovative connectomics platform and AI-driven solutions can revolutionize the diagnosis and treatment of brain disorders.

Our Opinion on the News

BrainSightAI's successful funding round highlights the growing investor confidence in AI-powered healthcare innovations. By focusing on international certifications and market expansion, the company is strategically positioning itself as a global leader in neuroinformatics. Its emphasis on precision diagnostics and personalized brain care is not only addressing critical healthcare challenges but also paving the way for improved patient outcomes worldwide.

For more details, visit BrainSightAI’s official website.

Source: Inc42